By contrast, the treatment with MATT and, in particular, with MATT‐LTSLs, reduced the number of tumor nodules to 6 and 2, respectively, being consistent well with the in vitro antimetastatic study described in Figure 2c–e. This evidence concerns the gene TMEM79 and neoplasm.